Literature DB >> 14720161

Shock on T versus direct current voltage for induction of ventricular fibrillation: a randomized prospective comparison.

Arjun D Sharma1, Eric Fain, P Gearoid O'Neill, Anne Skadsen, Roger Damle, Jim Baker, Vinod Chauhan, Meir Mazuz, Terrance Ross, Ziaozheng Zhang.   

Abstract

VF is induced during ICD implantation to determine efficacy of therapy. Establishing the best clinical method of induction of VF would potentially be beneficial in reducing the number of induction attempts and reducing the frequency of inadvertent induction of VT. Commonly used methods to induce VF include shock in the T wave vulnerable period (T shock) and high frequency stimulation. This study compared the efficacy of T shock with a new induction method using a 9-V DC pulse. The study was a randomized, prospective, case crossover trial in patients receiving ICDs. VF was induced by T shock and DC in a randomized sequence during an ICD implant. VF was induced at least four times in each patient (two T shocks and two DC inductions) and with each induction; attempts were continued with modifications until successful. A paired evaluation between the T shock/DC induction was performed in 37 patients (28 men, age 64 +/- 12 years) with a left ventricular ejection fraction of 0.40 +/- 0.20. Arrhythmia indications were VT (n = 23), VF (n = 10), and VT/VF (n = 4). Drug therapy included amiodarone (n = 10), metoprolol (n = 6), digoxin (n = 1), and lidocaine (n = 1). The average T shock voltage was 207.0 +/- 16.1 V. The S1 cycle drive length was consistently 400 ms, and the mean S2 coupling interval was 317.8 +/- 19.6 ms. The length of time DC applied averaged 3.8 +/- 1.4 seconds. A total of 148 episodes of VF were included in the analysis. T shock induced VF with a cycle length of 213.5 +/- 35.1 ms, and DC induced VF with a cycle length of 214.6 +/- 34.5 ms (P = 0.86). Although VF was eventually induced for each randomization, the number of attempts required were dependent on the method of induction. The successful DC first attempt VF induction rate was 96%, with three patients requiring two attempts during one of the DC inductions. T shock had a 68% first attempt success rate with 21 patients requiring multiple T shocks to induce VF. All nine female patients had at least one unsuccessful first attempt T shock, which contributed to an overall unsuccessful first attempt induction rate significantly higher in women then men (36.1% vs 12.5%, P = 0.001). A constant DC voltage induction of VF may be more effective than T shock for induction of VF in a clinical setting because it reduces the number of attempts required to induce VF. By either method, VF appears to be more difficult to induce in women. DC induction has the advantage of simple programming of only duration of stimulation. These findings have implications particularly for ICD implantation with conscious sedation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720161     DOI: 10.1111/j.1540-8159.2004.00391.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Effectiveness of VF induction with DC fibber versus conventional induction methods in patients on chronic amiodarone therapy.

Authors:  Jason C Rubenstein; Manish S Gupta; Michael H Kim
Journal:  J Interv Card Electrophysiol       Date:  2013-09-08       Impact factor: 1.900

2.  Induction by direct current pulse versus 50-Hz pacing on ventricular fibrillation and defibrillation.

Authors:  Hoong Sern Lim; Sharon Flannigan; Howard Marshall
Journal:  J Interv Card Electrophysiol       Date:  2010-05-12       Impact factor: 1.900

Review 3.  Optimizing defibrillation waveforms for ICDs.

Authors:  Mark W Kroll; Charles D Swerdlow
Journal:  J Interv Card Electrophysiol       Date:  2007-06-01       Impact factor: 1.900

4.  Mechanism of reentry induction by a 9-V battery in rabbit ventricles.

Authors:  Martin J Bishop; Rebecca A B Burton; Manish Kalla; Kumaraswamy Nanthakumar; Gernot Plank; Gil Bub; Edward J Vigmond
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.